ALCON INC reported a 10% revenue increase to $2.69 billion in the first quarter of 2026. Net sales missed the $2.71 billion estimate set by LSEG analysts as implantable segment growth stalled. The miss highlights investor concerns about competitive pressures offsetting new product momentum.

Competitive Pressure in Implantables